[News] Unauthorised cancer drug in Zimbabwe raises patient safety concerns

On Jan 27, 2026, Zimbabwe's Medicines Control Authority (MCAZ) alerted citizens about the circulation of an unauthorised formulation of goserelin acetate, a hormone therapy used in the treatment of prostate and breast cancer. It warned that the product could pose risks to patient safety. “Our records show that this product was not formally imported into Zimbabwe. The MCAZ cannot therefore…